Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2005-08-02
2005-08-02
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C562S464000, C514S567000, C514S529000, C514S532000, C514S648000, C514S620000, C514S665000, C514S666000, C560S036000, C560S129000, C564S164000, C564S165000, C564S305000, C564S337000, C568S027000, C568S028000, C568S030000, C568S041000, C568S042000
Reexamination Certificate
active
06924391
ABSTRACT:
Inhibitors of the cytosolic phospholypase A2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formulawherein X, Z, X1, R1, R2, Ra, Rb, R3, R4and Y are as defined in the specification.
REFERENCES:
patent: 5453443 (1995-09-01), Perrier et al.
patent: 5478857 (1995-12-01), Clemens et al.
patent: 5866318 (1999-02-01), Rydel et al.
patent: 5-222006 (1993-08-01), None
patent: 09268153 (1996-04-01), None
patent: WO 97/21676 (1997-06-01), None
patent: WO 98/08818 (1998-03-01), None
patent: WO 98/25893 (1998-06-01), None
patent: WO 99/15129 (1999-04-01), None
patent: 0009114 (2000-02-01), None
I. P. Street, et al, “Slow- and Tight-Binding Inhibitors of the 85-kDa Human Phospholipase A2,” BIOCHEMISTRY, 32, pp. 5935-5940, 1993.
K. M. Abdullah, et al, “Synthesis and Preparation of an Affinity Chromatography Column for the Purification of Cytosolic Phospholipase A2,” Bioorganic & Medicinal Chemistry Letters, 5(5), pp. 519-522, 1995.
D. L. Boger, et al, “Trifluoromethyl Ketone Inhibitors of Fatty Acid Amide Hydrolase: A Probe of Structural and Conformational Features Contributing to Inhibition,” Bioorganic & Medicinal Chemistry Letters, 9, pp. 265-270, 1999.
P. Norman, “Medicinal Chemistry in Eastern England-Ninth Symposium,” IDRUGS, 1(1), pp. 49-54, 1998.
L. A. Clemens, et al, “Reactive Glia Express Cytosolic Phospholipase A2 After Transient Global orebrain Ischemia in the Rat,” STROKE, 27(3), pp. 527-535, 1996.
D. T. Stephenson, et al, “Cytosolic Phospholipase A2 (cPLA2) Immunoreactivity is Elevated in Alzheimer's Disease Brain,” Neurobiology of Disease, 3, pp. 51-63, 1996.
Z. Huang, et al, “Methyl Arachidonyl Fluorophosphonate, a Potent Irreversible cPLA2 Inhibitor, Blocks the Mobilization of Arachidonic Acid in Human Platelets and Neutrophils,” Mediators of Inflammation, 3, pp. 307-308, 1994.
A. Gresham, et al, “Increased Synthesis of High-Molecular -Weight cPLA2 Mediates Early UV-Induced PGE2 in Human Skin,” American Journal of Physiology, 270, pp. C1037-C1050, 1996.
J. Balsinde, et al, “Distinct Roles in Signal Transduction for Each of the Phospholipase A2 Enzymes Present in P388D1 Macrophages,” Journal of Biological Chemistry, 271(12), pp. 6758-6765, 1996.
Balasubramanian Neelakantan
Banville Jacques
Bouthillier Gilles
Martel Alain
Remillard Roger
Bristol--Myers Squibb Company
Kumar Shailendra
Mingo Pamela A.
LandOfFree
Alpha-amino,-thio,-oxo substituted ketones as phospholipase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha-amino,-thio,-oxo substituted ketones as phospholipase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-amino,-thio,-oxo substituted ketones as phospholipase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3522882